OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES

JK Choi, W Xiao, X Chen, S Loghavi… - Modern Pathology, 2024 - Elsevier
This manuscript represents a review of lymphoblastic leukemia/lymphoma (acute
lymphoblastic leukemia/lymphoblastic lymphoma), acute leukemias of ambiguous lineage …

CD30+ anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features

H Stein, HD Foss, H Dürkop… - Blood, The Journal …, 2000 - ashpublications.org
Anaplastic large cell lymphoma (ALCL) represents a generally recognized group of large
cell lymphomas. Defining features consist of a proliferation of predominantly large lymphoid …

[引用][C] Pathology and genetics of tumours of haematopoietic and lymphoid tissues

ES Jaffe - World Health Organization classification of tumor …, 2001 - books.google.com
This is the third volume in the new World Health Organization series on histological and
genetic typing of tumours. Tumours of the haematopoietic and lymphoid tissues are covered …

ALK anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified …

KJ Savage, NL Harris, JM Vose, F Ullrich… - Blood, The Journal …, 2008 - ashpublications.org
Abstract The International Peripheral T-Cell Lymphoma Project is a collaborative effort
designed to gain better understanding of peripheral T-cell and natural killer (NK)/T-cell …

[HTML][HTML] ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor

CM Coffin, A Patel, S Perkins, KSJ Elenitoba-Johnson… - Modern Pathology, 2001 - Elsevier
Background: Inflammatory myofibroblastic tumor (IMT) is an uncommon tumor of
extrapulmonary and pulmonary tissues with an unpredictable clinical course, occasional …

ALK+ Lymphoma: Clinico-Pathological Findings and Outcome

B Falini, S Pileri, PL Zinzani, A Carbone… - Blood, The Journal …, 1999 - ashpublications.org
A distinct pathologic entity (ALK+ lymphoma) that is characterized by expression of the
anaplastic lymphoma kinase (ALK) protein has recently emerged within the heterogeneous …

A Novel, Highly Sensitive Antibody Allows for the Routine Detection of ALK-Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry

M Mino-Kenudson, LR Chirieac, K Law, JL Hornick… - Clinical Cancer …, 2010 - AACR
Purpose: Approximately 5% of lung adenocarcinomas harbor an EML4-ALK gene fusion
and define a unique tumor group that may be responsive to targeted therapy. However ALK …

A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells

B Falini, M Fizzotti, A Pucciarini… - Blood, The Journal …, 2000 - ashpublications.org
A new monoclonal antibody (MUM1p) was used to study the cell/tissue expression of human
MUM1/IRF4 protein, the product of the homologous gene involved in the myeloma …

EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues

MP Martelli, G Sozzi, L Hernandez, V Pettirossi… - The American journal of …, 2009 - Elsevier
A fusion gene, echinoderm microtubule associated protein like 4–anaplastic lymphoma
kinase (EML4-ALK), with transforming activity has recently been identified in a subset of non …

[HTML][HTML] Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases

MH Cessna, H Zhou, WG Sanger, SL Perkins, S Tripp… - Modern Pathology, 2002 - Elsevier
Abnormalities of chromosome 2p23 with expression of ALK1 and p80 occur in both
inflammatory myofibroblastic tumor (IMT) and anaplastic large cell lymphoma. This …